IL165840A0 - Combination therapy wherein a serotonin reuptake inhibitor is used - Google Patents
Combination therapy wherein a serotonin reuptake inhibitor is usedInfo
- Publication number
- IL165840A0 IL165840A0 IL16584003A IL16584003A IL165840A0 IL 165840 A0 IL165840 A0 IL 165840A0 IL 16584003 A IL16584003 A IL 16584003A IL 16584003 A IL16584003 A IL 16584003A IL 165840 A0 IL165840 A0 IL 165840A0
- Authority
- IL
- Israel
- Prior art keywords
- disorder
- disorders
- serotonin reuptake
- anxiety
- reuptake inhibitor
- Prior art date
Links
- 239000003772 serotonin uptake inhibitor Substances 0.000 title abstract 3
- 229940126570 serotonin reuptake inhibitor Drugs 0.000 title abstract 2
- 238000002648 combination therapy Methods 0.000 title 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 208000032841 Bulimia Diseases 0.000 abstract 1
- 206010006550 Bulimia nervosa Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 206010013654 Drug abuse Diseases 0.000 abstract 1
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000011688 Generalised anxiety disease Diseases 0.000 abstract 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- 206010036618 Premenstrual syndrome Diseases 0.000 abstract 1
- 206010041250 Social phobia Diseases 0.000 abstract 1
- 208000031674 Traumatic Acute Stress disease Diseases 0.000 abstract 1
- 208000026345 acute stress disease Diseases 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 208000024732 dysthymic disease Diseases 0.000 abstract 1
- 208000029364 generalized anxiety disease Diseases 0.000 abstract 1
- 229940125425 inverse agonist Drugs 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000004031 partial agonist Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000019899 phobic disease Diseases 0.000 abstract 1
- 208000028173 post-traumatic stress disease Diseases 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 239000002469 receptor inverse agonist Substances 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Finger-Pressure Massage (AREA)
- Radiation-Therapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39085102P | 2002-06-20 | 2002-06-20 | |
| DKPA200200943 | 2002-06-20 | ||
| PCT/DK2003/000412 WO2004000326A1 (en) | 2002-06-20 | 2003-06-19 | Combination therapy wherein a serotonin reuptake inhibitor is used |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL165840A0 true IL165840A0 (en) | 2006-01-15 |
Family
ID=30001771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16584003A IL165840A0 (en) | 2002-06-20 | 2003-06-19 | Combination therapy wherein a serotonin reuptake inhibitor is used |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20050288355A1 (de) |
| EP (1) | EP1545552B1 (de) |
| JP (1) | JP2005533069A (de) |
| KR (1) | KR20050012284A (de) |
| CN (1) | CN100430063C (de) |
| AT (1) | ATE357920T1 (de) |
| AU (1) | AU2003240434A1 (de) |
| BR (1) | BR0311503A (de) |
| CA (1) | CA2490638C (de) |
| DE (1) | DE60312874T2 (de) |
| DK (1) | DK1545552T3 (de) |
| ES (1) | ES2282632T3 (de) |
| IL (1) | IL165840A0 (de) |
| MX (1) | MXPA04012693A (de) |
| NO (1) | NO20045552L (de) |
| NZ (1) | NZ536624A (de) |
| PL (1) | PL373729A1 (de) |
| PT (1) | PT1545552E (de) |
| WO (1) | WO2004000326A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060223857A1 (en) * | 2003-08-21 | 2006-10-05 | Michael Didriksen | Combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
| US7402680B2 (en) * | 2003-09-17 | 2008-07-22 | Janssen Pharmaceutica, N.V. | Fused heterocyclic compounds |
| JP5646126B2 (ja) | 2003-12-11 | 2014-12-24 | サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | 鎮静剤と神経伝達物質調節剤の併用、および睡眠の質の向上方法および鬱の治療方法 |
| US7598255B2 (en) | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
| HUE036004T2 (hu) * | 2007-08-03 | 2018-06-28 | Richter Gedeon Nyrt | Dopamin receptor ligandumokat tartalmazó gyógyszerkészítmények és kezelési eljárások dopamin receptor ligandumok alkalmazásával |
| CN107556206A (zh) * | 2016-06-30 | 2018-01-09 | 陕西合成药业股份有限公司 | 一种新型5‑羟色胺再摄取抑制剂类化合物及其制备方法和在医学上的应用 |
| CN111107878A (zh) * | 2017-04-10 | 2020-05-05 | 夏尔制药公司 | 使用苯丙胺前药的治疗方法 |
| WO2020014302A1 (en) * | 2018-07-11 | 2020-01-16 | Rosenberg Leon I | Therapeutic combinations for treatment of cns disorders |
| WO2020087031A1 (en) | 2018-10-26 | 2020-04-30 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
| PL4009942T3 (pl) * | 2019-08-06 | 2024-04-08 | Initiator Pharma A/S | Związek służący do leczenia skojarzonego |
| WO2025018810A1 (ko) * | 2023-07-18 | 2025-01-23 | 주식회사 지오비스타 | 동물에 대한 정신질환 또는 행동장애의 예방 또는 치료용 조성물 |
| CN117257815A (zh) * | 2023-11-20 | 2023-12-22 | 中国人民解放军军事科学院军事医学研究院 | Cgp35348在制备抗抑郁药物中的新用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9801538D0 (en) * | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
| US6176242B1 (en) * | 1999-04-30 | 2001-01-23 | Medtronic Inc | Method of treating manic depression by brain infusion |
-
2003
- 2003-06-19 PT PT03729907T patent/PT1545552E/pt unknown
- 2003-06-19 JP JP2004514582A patent/JP2005533069A/ja not_active Withdrawn
- 2003-06-19 AU AU2003240434A patent/AU2003240434A1/en not_active Abandoned
- 2003-06-19 US US10/516,519 patent/US20050288355A1/en not_active Abandoned
- 2003-06-19 EP EP03729907A patent/EP1545552B1/de not_active Expired - Lifetime
- 2003-06-19 AT AT03729907T patent/ATE357920T1/de not_active IP Right Cessation
- 2003-06-19 MX MXPA04012693A patent/MXPA04012693A/es active IP Right Grant
- 2003-06-19 DK DK03729907T patent/DK1545552T3/da active
- 2003-06-19 BR BR0311503-8A patent/BR0311503A/pt not_active IP Right Cessation
- 2003-06-19 IL IL16584003A patent/IL165840A0/xx unknown
- 2003-06-19 NZ NZ536624A patent/NZ536624A/en unknown
- 2003-06-19 DE DE60312874T patent/DE60312874T2/de not_active Expired - Fee Related
- 2003-06-19 PL PL03373729A patent/PL373729A1/xx not_active Application Discontinuation
- 2003-06-19 CN CNB038144387A patent/CN100430063C/zh not_active Expired - Fee Related
- 2003-06-19 ES ES03729907T patent/ES2282632T3/es not_active Expired - Lifetime
- 2003-06-19 WO PCT/DK2003/000412 patent/WO2004000326A1/en not_active Ceased
- 2003-06-19 KR KR10-2004-7020393A patent/KR20050012284A/ko not_active Ceased
- 2003-06-19 CA CA002490638A patent/CA2490638C/en not_active Expired - Fee Related
-
2004
- 2004-12-20 NO NO20045552A patent/NO20045552L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1662246A (zh) | 2005-08-31 |
| CA2490638C (en) | 2008-01-22 |
| CN100430063C (zh) | 2008-11-05 |
| DE60312874T2 (de) | 2008-01-17 |
| PL373729A1 (en) | 2005-09-05 |
| AU2003240434A1 (en) | 2004-01-06 |
| EP1545552A1 (de) | 2005-06-29 |
| ATE357920T1 (de) | 2007-04-15 |
| EP1545552B1 (de) | 2007-03-28 |
| BR0311503A (pt) | 2005-02-22 |
| MXPA04012693A (es) | 2005-03-23 |
| US20050288355A1 (en) | 2005-12-29 |
| NO20045552L (no) | 2004-12-20 |
| NZ536624A (en) | 2008-04-30 |
| KR20050012284A (ko) | 2005-01-31 |
| CA2490638A1 (en) | 2003-12-31 |
| PT1545552E (pt) | 2007-06-15 |
| DE60312874D1 (de) | 2007-05-10 |
| ES2282632T3 (es) | 2007-10-16 |
| DK1545552T3 (da) | 2007-08-06 |
| JP2005533069A (ja) | 2005-11-04 |
| WO2004000326A1 (en) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165840A0 (en) | Combination therapy wherein a serotonin reuptake inhibitor is used | |
| RS20120158A3 (en) | Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors | |
| EA200600049A1 (ru) | Способы получения 3 - бензазепинов | |
| NO20083204L (no) | Kombinasjon av en H3-antagonist/inversagonist og en appetittdemper | |
| UA82828C2 (en) | The use of enantiomeric pure escitalopram for treatment of depression | |
| CY1108464T1 (el) | Παραγωγα 4-(2-φαινυλοσουλφανυλο-φαινυλο)πιπεριδινης, ως αναστολεις επαναπροσληψεως σεροτονινης | |
| BR0306147A (pt) | Uso de um composto ou combinação de compostos tendo atividade agonìstica de receptor de dopamina-d2 parcial e atividade inibidora de reabsorção da serotonina e/ou noradrenalina, método para a preparação de uma composição, e, composição | |
| DK2035375T3 (da) | 1,3 Disubstituerede 4-methyl-1H pyrrol-2-carboxamider og deres anvendelse til fremstilling af lægemidler | |
| WO2005056056A3 (en) | The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist | |
| JP2006514952A5 (de) | ||
| DE60201829D1 (de) | Azaheterocyclylmethyl derivative des 2,3-dihydro-1,4-dioxino(2,3-f)quinolins als antidepressiva | |
| EA200601158A1 (ru) | Комбинация ингибитора обратного захвата серотонина и антагониста, обратного агониста или частичного агониста рецептора гистамина 3 | |
| NO20035673L (no) | Nye heteroarylderivater, deres fremstilling og anvendelse | |
| AU2002256334A1 (en) | Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino(2,3-f)quinoxaline | |
| WO2006012476A3 (en) | Method for treating nervous system disorders and conditions | |
| NO20061167L (no) | Kombinasjonen av en serotonin-reopptaksinhibitor og en glysintransporter type 1-inhibitor for behandling av depresjon | |
| BR0314513A (pt) | Derivados de indolealquil antidepressivo de benzodioxano metilaminas fundidos por heterociclo | |
| BRPI0511529A (pt) | combinação terapêutica para distúrbios de hiperatividade/déficit de atenção | |
| CO5680440A2 (es) | Terapia de combinacion en donde se utiliza un inhibidor de recaptacion de serotonina | |
| ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
| IL139211A0 (en) | New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol | |
| EA200600453A1 (ru) | Комбинация ингибитора обратного захвата серотонина и ингибитора переносчика глицина типа 1 для лечения депрессии | |
| ATE418553T1 (de) | Histamin-h3-rezeptor inhibitoren, ihre herstellung und therapeutische anwendungen | |
| EA200600531A1 (ru) | Сочетание ингибитора обратного захвата серотонина и локсапина | |
| UA85198C2 (ru) | Производные морфолина как ингибиторы повторного поглощения норэпинефрина |